China National Pharmaceutical Group

LAM signs distribution agreement with Chinese firm

Published in Patient Care Law Weekly, May 2nd, 2004

LAM Pharmaceutical Corp. (LAMP) has signed an agreement with China National Pharmaceutical Foreign Trade Corp. (Sinopharm Foreign Trade), a sales arm of China National Pharmaceutical Group (Sinopharm Group), for the distribution of LAM's IPM Wound Gel throughout China.

Dating back to 1950s, Sinopharm Group has evolved from the former State Pharmaceutical Administration of China into what it says is the largest pharmaceutical distribution system today with the most extensive market coverage in all regions of China. Sinopharm Group markets both Chinese and western pharmaceutical products, medical devices, and pharmaceutical and chemical materials.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Patient Care Law Weekly

Source: Patient Care Law Weekly (2004-05-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry